The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: A possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart
Johann Wojta
Journal of Molecular and Cellular Cardiology, 2005
View PDFchevron_right
The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure
Ayse Vera Cetinkaya
International Journal of Molecular Sciences
View PDFchevron_right
Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction
Lawrence W Dobrucki
Journal of Biological Chemistry, 2010
View PDFchevron_right
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
Marina Bergman
American Journal of Physiology-Heart and Circulatory Physiology, 2006
View PDFchevron_right
Myocardial matrix metalloproteinase-2: inside out and upside down
Francisco Chong Villarreal
Journal of molecular and cellular cardiology, 2014
View PDFchevron_right
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
C. McTiernan
Cardiovascular Research, 2000
View PDFchevron_right
Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2
Guoqi Teng
Cardiovascular Pathology, 2014
View PDFchevron_right
Matrix metalloproteinases and their function in myocardium
Karel Kotaska
Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2005
View PDFchevron_right
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes
Péter Bencsik
Cardiovascular Drugs and Therapy
View PDFchevron_right
Cardiac-Restricted Overexpression of Membrane Type1 Matrix Metalloproteinase in Mice Effects on Myocardial Remodeling With Aging
Christy Beck
View PDFchevron_right
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart
Wang Wang
2000
View PDFchevron_right
Paradigmatic identification of MMP-2 and MT1-MMP activation systems in cardiac fibroblasts cultured as a monolayer
Martin Elliott, Chun Guo
Journal of Cellular Biochemistry, 2005
View PDFchevron_right
Type I Collagen-induced MMP-2 Activation Coincides with Up-regulation of Membrane Type 1-Matrix Metalloproteinase and TIMP-2 in Cardiac Fibroblasts
Chun Guo
View PDFchevron_right
MMP induction and inhibition in myocardial infarction
Merry Lindsey
Heart failure reviews, 2004
View PDFchevron_right
Inhibition of MMP-2 expression affects metabolic enzyme expression levels: Proteomic analysis of rat cardiomyocytes
Francisco Cayabyab
Journal of Proteomics, 2014
View PDFchevron_right
Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte
Hernando León
British Journal of Pharmacology, 2008
View PDFchevron_right
Titin is a Target of Matrix Metalloproteinase-2: Implications in Myocardial Ischemia/Reperfusion Injury
Henk Granzier
Circulation, 2010
View PDFchevron_right
Role of extracellular matrix metalloproteinases in cardiac remodelling
Hanumanth Reddy
Heart Failure Reviews, 1996
View PDFchevron_right
Matrix Metalloproteinase Inhibition After Myocardial Infarction
Jack Cleutjens
Circulation Research, 2001
View PDFchevron_right
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy
Gonzalo De La Morena
American Heart Journal, 2008
View PDFchevron_right
M atrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction
Wilma Suarez-pinzon, Xiaonan Gao
2000
View PDFchevron_right
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Erik Young
Journal of Clinical Investigation, 2000
View PDFchevron_right
Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure?
Jack Cleutjens
Circulation Research, 2001
View PDFchevron_right
MMP-2 is localized to the mitochondria-associated membrane of the heart
Woo Jung Cho
American Journal of Physiology-Heart and Circulatory Physiology, 2013
View PDFchevron_right
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
Heinz-peter Schultheiss, Sophie Van Linthout
Basic Research in Cardiology, 2008
View PDFchevron_right
Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction
Jamie Crawford
Circulation, 2002
View PDFchevron_right
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells
you charles
View PDFchevron_right
Matrix Metalloproteinases in Myocardial Infarction and Heart Failure
Cesar A Meschiari
Progress in molecular biology and translational science, 2017
View PDFchevron_right